Early bone molecular changes signal osteoarthritis progression
Osteoarthritis often goes undetected until cartilage damage is advanced, limiting treatment options. A new study shows that molecular…
SN101 iPSC-derived therapy relieves chronic pain and preserves joints
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on a novel approach…
Blocking a ‘gerozyme’ reverses cartilage loss in mice
An injection that blocks the activity of a protein involved in aging reverses naturally occurring cartilage loss in…